Unverified50% confidenceOpinionExact time
As the cost of tools such as gene synthesis, gene editing, and AI-assisted protein design has dropped substantially, the threshold for obtaining and modifying biological materials has continued to fall, expanding biosafety risks from state actors to non-state actors and even individuals.
1
Sources
50%
Confidence
Long-term
Relevance
10/13/2026
First Seen
Sources
Related Entities
Related Claims
UnverifiedIntroducing large language models into biological research may lower the knowledge threshold for synthesizing dangerous substances or designing experimental protocols, amplifying dual-use concerns.75% similarUnverifiedSome experts have warned that large AI models may lower the threshold for creating biological threats.73% similarUnverifiedTargeted nativization of the actual performance bottlenecks in an application is often more pragmatic than starting from scratch67% similarUnverifiedThe stickiness of life science experimental costs stems primarily from regulatory compliance requirements (GLP/GMP standards), inherent variability in biological systems, and the high concentration of the reagent and consumables supply chain.66% similarUnverifiedThe performance penalty from mismatched history stems not from the history content itself but from permanent clamping; if the transplanted state is allowed to evolve naturally, the burden is substantially reduced.66% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/1021852API
curl https://kongchang.com/api/v1/knowledge/claims/1021852MCP
get_claim(id=1021852)